uniQure

+$0.74 (+2.33%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell uniQure and other stocks, options, and ETFs commission-free!

About QURE

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.

CEO
Matthew C. Kapusta
Employees
332
Headquarters
Amsterdam, Noord-Holland
Founded
1998

QURE Key Statistics

Market Cap
1.54B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
397.39K
High Today
$32.64
Low Today
$31.50
Open Price
$31.64
Volume
303.36K
52 Week High
$71.45
52 Week Low
$28.58

QURE Earnings

-$1.21
-$0.28
$0.65
$1.58
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$1.58 per share
Actual
-$0.91 per share

You May Also Like

GSAQU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure